Views

CrossRef citations to date

Altmetric

Omalizumab treatment in patients with severe chronic spontaneous urticaria: consideration on efficacy from real-life experiences

Omalizumab therapy in a patient with cronic spontaneous urticaria, ulcerative colitis, hypereosinophilia and prurigo Besnier: a case report

T. GriecoDermatologic Clinic Sapienza University of Rome, Rome, Italy; Correspondence[email protected]
View further author information

C. ChelloDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information

V. FainaDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information

V. V. GomesUOC Anatomical Pathology, Belcolle Hospital, Viterbo, Italy; View further author information

L. AleiDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information

A. SernicolaDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information

V. PanasitiCampus Bio Medico, Dermatologic Clinic, Rome, ItalyView further author information

S. CalvieriDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information

show all

Abstract

The case of a woman who suffered from CSU and prurigo Besnier, with a history of chronic hyper-eosinophilia, ulcerative colitis and thyroiditis, unresponsive to anti-histamines and steroids is reported. The patient received omalizumab treatment, and obtained resolution of urticaria along with improvement of cutaneous symptoms of prurigo.

KEYWORDS:

Acknowledgements

Medical writing assistance of this paper was provided by Laura Brogelli, on behalf of Content Ed Net; this assistance was funded by Novartis.

Disclosure statement

The authors report no conflict of interest.

Additional information

Funding

This supplement was funded by Novartis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Omalizumab therapy in a patient with cronic spontaneous urticaria, ulcerative colitis, hypereosinophilia and prurigo Besnier: a case report

Information for

Open access

Opportunities

Help and information

Omalizumab therapy in a patient with cronic spontaneous urticaria, ulcerative colitis, hypereosinophilia and prurigo Besnier: a case report

Abstract

Acknowledgements

Disclosure statement

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature